These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27012889)

  • 1. Effects of varenicline on alpha4-containing nicotinic acetylcholine receptor expression and cognitive performance in mice.
    Lange-Asschenfeldt C; Schäble S; Suvorava T; Fahimi EG; Bisha M; Stermann T; Henning U; Kojda G
    Neuropharmacology; 2016 Aug; 107():100-110. PubMed ID: 27012889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
    J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive improvements in a mouse model with substituted 1,2,3-triazole agonists for nicotinic acetylcholine receptors.
    Arunrungvichian K; Boonyarat C; Fokin VV; Taylor P; Vajragupta O
    ACS Chem Neurosci; 2015 Aug; 6(8):1331-40. PubMed ID: 25978789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline enhances recognition memory via α7 nicotinic acetylcholine receptors in the medial prefrontal cortex in male mice.
    Esaki H; Deyama S; Izumi S; Katsura A; Nishikawa K; Nishitani N; Kaneda K
    Neuropharmacology; 2023 Nov; 239():109672. PubMed ID: 37506875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits.
    Vieira-Brock PL; McFadden LM; Nielsen SM; Smith MD; Hanson GR; Fleckenstein AE
    Int J Neuropsychopharmacol; 2015 Jul; 18(12):. PubMed ID: 26164716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption.
    Hendrickson LM; Zhao-Shea R; Pang X; Gardner PD; Tapper AR
    J Neurosci; 2010 Jul; 30(30):10169-76. PubMed ID: 20668200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic acetylcholine receptors containing the α4 subunit are critical for the nicotine-induced reduction of acute voluntary ethanol consumption.
    Hendrickson LM; Gardner P; Tapper AR
    Channels (Austin); 2011; 5(2):124-7. PubMed ID: 21239887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
    Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
    Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.
    de Bruin NM; Prickaerts J; van Loevezijn A; Venhorst J; de Groote L; Houba P; Reneerkens O; Akkerman S; Kruse CG
    Neurobiol Learn Mem; 2011 Sep; 96(2):392-402. PubMed ID: 21757018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-low exposure to α-7 nicotinic acetylcholine receptor partial agonists elicits an improvement in cognition that corresponds with an increase in α-7 receptor expression in rodents: implications for low dose clinical efficacy.
    Werkheiser JL; Sydserff S; Hubbs SJ; Ding M; Eisman MS; Perry D; Williams AJ; Smith JS; Mrzljak L; Maier DL
    Neuroscience; 2011 Jul; 186():76-87. PubMed ID: 21550383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting activity of (α4)
    Wang J; Blasio A; Chapman HL; Doebelin C; Liaw V; Kuryatov A; Giovanetti SM; Lindstrom J; Lin L; Cameron MD; Kamenecka TM; Pomrenze MB; Messing RO
    Neuropsychopharmacology; 2020 Jan; 45(2):301-308. PubMed ID: 31394567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with varenicline changes expression of four nAChR binding sites in mice.
    Marks MJ; O'Neill HC; Wynalda-Camozzi KM; Ortiz NC; Simmons EE; Short CA; Butt CM; McIntosh JM; Grady SR
    Neuropharmacology; 2015 Dec; 99():142-55. PubMed ID: 26192545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procognitive effect of AC-3933 in aged mice, and synergistic effect of combination with donepezil in scopolamine-treated mice.
    Hashimoto T; Hatayama Y; Nakamichi K; Yoshida N
    Eur J Pharmacol; 2014 Dec; 745():123-8. PubMed ID: 25446931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willughbeia cochinchinensis prevents scopolamine-induced deficits in memory, spatial learning, and object recognition in rodents.
    Can MV; Tran AH; Pham DM; Dinh BQ; Le QV; Nguyen BV; Nguyen MTT; Nguyen HX; Nguyen NT; Nishijo H
    J Ethnopharmacol; 2018 Mar; 214():99-105. PubMed ID: 28652013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
    Gotti C; Moretti M; Meinerz NM; Clementi F; Gaimarri A; Collins AC; Marks MJ
    Mol Pharmacol; 2008 Jun; 73(6):1796-807. PubMed ID: 18337473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the nicotinic agonist varenicline on the performance of tasks of cognition in aged and middle-aged rhesus and pigtail monkeys.
    Terry AV; Plagenhoef M; Callahan PM
    Psychopharmacology (Berl); 2016 Mar; 233(5):761-71. PubMed ID: 26612616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.
    Rollema H; Hajós M; Seymour PA; Kozak R; Majchrzak MJ; Guanowsky V; Horner WE; Chapin DS; Hoffmann WE; Johnson DE; McLean S; Freeman J; Williams KE
    Biochem Pharmacol; 2009 Oct; 78(7):813-24. PubMed ID: 19501054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.
    Lu P; Mamiya T; Lu L; Mouri A; Niwa M; Kim HC; Zou LB; Nagai T; Yamada K; Ikejima T; Nabeshima T
    Behav Brain Res; 2010 Mar; 207(2):387-93. PubMed ID: 19857526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
    Prickaerts J; van Goethem NP; Chesworth R; Shapiro G; Boess FG; Methfessel C; Reneerkens OA; Flood DG; Hilt D; Gawryl M; Bertrand S; Bertrand D; König G
    Neuropharmacology; 2012 Feb; 62(2):1099-110. PubMed ID: 22085888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
    de Bruin NM; Prickaerts J; Lange JH; Akkerman S; Andriambeloson E; de Haan M; Wijnen J; van Drimmelen M; Hissink E; Heijink L; Kruse CG
    Neurobiol Learn Mem; 2010 May; 93(4):522-31. PubMed ID: 20132903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.